January 8, 2022

This week on “Money Talks,” the Henssler Research Analysts discuss what they believe 2022 holds for the stock market. Chief Investment Officer, Troy Harmon, CFA, CVA, and Research Analysts Nick Antonucci, CVA, CEPA, and Jacob Keen, CFA, examine how the top and bottom movers in the S&P are indicative of the current market cycle. The Analysts cover inflation, government spending, performance concentration in a few stocks and the chances of growth in 2022.

Check out the show segments using the chapter controls in the player above.

  • Market Roundup: Covering the week of Jan. 3 – Jan. 7, 2022
  • Top 10 Movers: Insights into the current market cycle
  • Investment Whys: 2022 Outlook
This article is for demonstrative and academic purposes and is meant to provide valuable background information on particular investments, NOT a recommendation to buy. The investments referenced within this article may currently be traded by Henssler Financial. All material presented is compiled from sources believed to be reliable and current, but accuracy cannot be guaranteed. The contents are intended for general information purposes only. Information provided should not be the sole basis in making any decisions and is not intended to replace the advice of a qualified professional, such as a tax consultant, insurance adviser or attorney. Although this material is designed to provide accurate and authoritative information with respect to the subject matter, it may not apply in all situations. Readers are urged to consult with their adviser concerning specific situations and questions. This is not to be construed as an offer to buy or sell any financial instruments. It is not our intention to state, indicate or imply in any manner that current or past results are indicative of future profitability or expectations. As with all investments, there are associated inherent risks. Please obtain and review all financial material carefully before investing. Henssler is not licensed to offer or sell insurance products, and this overview is not to be construed as an offer to purchase any insurance products.